Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,969 | -43,555 | -28,476 | -71,136 | -74,936 |
| Depreciation Amortization | -5,606 | -1,068 | -459 | 2,020 | 1,978 |
| Accounts receivable | -513 | 4,406 | -4,231 | N/A | N/A |
| Accounts payable and accrued liabilities | 8,191 | 661 | 2,280 | -720 | 948 |
| Other Working Capital | -351 | 4,862 | -1,653 | -1,526 | -1,186 |
| Other Operating Activity | 5,068 | -2,167 | 3,469 | 11,831 | 9,173 |
| Operating Cash Flow | $-78,180 | $-36,861 | $-29,070 | $-59,531 | $-64,023 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -286,707 | 20,363 | -59,680 | 90,000 | 85,500 |
| PPE Investments | -105 | -110 | -139 | -1,264 | -400 |
| Purchase Of Investment | N/A | N/A | N/A | -45,308 | -95,735 |
| Investing Cash Flow | $-286,812 | $20,253 | $-59,819 | $43,428 | $-10,635 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 377 | N/A | N/A | N/A |
| Debt Repayment | N/A | -377 | N/A | N/A | N/A |
| Common Stock Issued | 40,290 | 5 | N/A | 3,504 | 68,036 |
| Other Financing Activity | 215,333 | 133,569 | 96,676 | 86,097 | -297 |
| Financing Cash Flow | $255,623 | $133,574 | $96,676 | $89,601 | $67,739 |
| Beginning Cash Position | 132,391 | 15,425 | 7,638 | 59,932 | 66,851 |
| End Cash Position | 23,022 | 132,391 | 15,425 | 133,430 | 59,932 |
| Net Cash Flow | $-109,369 | $116,966 | $7,787 | $73,498 | $-6,919 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,180 | -36,861 | -29,070 | -59,531 | -64,023 |
| Capital Expenditure | -105 | -110 | -139 | -1,264 | -400 |
| Free Cash Flow | -78,285 | -36,971 | -29,209 | -60,795 | -64,423 |